Applegate’s MS Misdiagnosis Highlights Diagnostic Gaps in Neurology

3 min read
Source: Fox News
Applegate’s MS Misdiagnosis Highlights Diagnostic Gaps in Neurology
Photo: Fox News
TL;DR

Christina Applegate revealed she was misdiagnosed with multiple sclerosis (MS) in 2021, a case that underscores the difficulty of distinguishing MS from other conditions. While she experienced symptoms and MRI lesions typical of MS, her B-cell levels remained stable, leading to a re-evaluation. Experts note that no single test confirms MS, and conditions like migraines or lupus can mimic its symptoms. New imaging techniques, such as the 'central vein sign,' aim to improve diagnostic accuracy, though access to specialists remains uneven.

Key points

  • Applegate was diagnosed with MS in 2021 after brain and spinal MRIs showed lesions, but her B-cell levels did not change during treatment, prompting a re-evaluation.
  • Her doctor concluded she did not have MS, leaving her with unexplained symptoms and no new diagnosis.
  • Dr. Marwa Kaisey noted that nearly one in five patients referred to MS clinics at UCLA and Cedars-Sinai were ultimately misdiagnosed.
  • Conditions such as migraines, lupus, and neuromyelitis optica can produce similar symptoms and MRI abnormalities, complicating diagnosis.
  • The 'central vein sign' is a newer MRI technique designed to distinguish MS lesions from those caused by other conditions.
  • Bruce Bebo of the National Multiple Sclerosis Society emphasized that while diagnostic tools have improved, access to specialists and accurate diagnosis remains a challenge.

Background

This story follows broader discussions on neurological misdiagnoses, such as earlier coverage of Billy Joel’s health issues related to normal pressure hydrocephalus, which also highlighted the complexities of brain-related conditions. The current focus is on the specific challenges of diagnosing MS, a disease with no single definitive test.

How outlets are covering it

Fox News and NBC News focus on the clinical challenges and the emotional impact of misdiagnosis, citing Applegate’s experience and expert opinions from Dr. Marwa Kaisey and Dr. Richard Ransohoff. STAT, through Bruce Bebo, emphasizes the systemic issues of diagnostic accuracy versus speed, highlighting the role of the National Multiple Sclerosis Society in advancing diagnostic criteria. While Fox News and NBC News stress the lack of a definitive test and the need for humility in diagnosis, STAT focuses on the balance between early diagnosis and accuracy, noting that advances in imaging and biomarkers are promising but require broader access and validation. All sources agree that misdiagnosis is common and that conditions like migraines can mimic MS, but they differ in emphasis: Fox News and NBC News highlight individual patient experiences, while STAT focuses on systemic improvements and access to care.

Why it matters

Misdiagnosis of MS can lead to unnecessary treatments and delays in addressing the actual condition, impacting patient outcomes. Accurate diagnosis is crucial for initiating appropriate therapies, which have advanced significantly in recent years. The case of Applegate highlights the need for improved diagnostic tools and access to specialists to prevent both misdiagnosis and delayed diagnosis.

What to watch

Further development and validation of diagnostic tools like the central vein sign and spinal fluid biomarkers are expected. There is a push for better access to neurologists and MS specialists, as well as improved education for primary care providers to recognize early signs of MS. Research into AI and data analytics may also aid in improving diagnostic precision in the future.

Share this article

Want the full story? Read the original reporting

Read on Fox News